Company: USPH
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013467
Chunk: 52

Company: U S PHYSICAL THERAPY INC /NV
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 52
---
 |         $447,571 |     |          $63,051 |     |       $(256,345) |     |      $3,419 |     |      $829,949 |

| (1) | Represents the grant date fair value of restricted stock awards earned and as reported in the “Stock Awards” column of the Summary Compensation Table for each applicable year. These shares were issued in March of the succeeding year. |

| (2) | Adjustments are equal to (i) the year-end fair value of restricted stock awards granted during the applicable year that are earned but not issued and therefore deemed outstanding and unvested as of the end of the year, (ii) the amount of the change in fair value as of the end of the applicable year (from the end of the prior fiscal year) of any restricted stock awards granted in prior years that are outstanding and unvested as of the end of the applicable year, and (iii) for restricted stock awards granted in prior years that vest in the applicable year, an amount equal to the change in fair value as of the vesting date (from the end of the prior fiscal year). |

| (3) | Restricted stock awards are valued using the market price of our stock. The closing market price of our stock was $88.71, $93.14, $81.03, $95.55, and $120.25as of December 31, 2024, 2023, 2022, 2021, and 2020, respectively. The closing market price of our stock when the PEO and other NEOs’ restricted stock awards vested was $93.14on January 1, 2024, $112.15on April 1, 2024, $91.31on July 1, 2024, $82.99on October 1, 2024, $81.03on January 1, 2023, $97.91on April 1, 2023, $121.39on July 1, 2023, $91.73on October 1, 2023, $95.55on January 1, 2022, $103.76on April 1, 2022, $112.30on July 1, 2022, $76.02on October 1, 2022, $120.25on January 1, 2021, $110.21on April